Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CD8: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CD8 is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, inhibits. Associated with ALS, Aging, Als. Connected to 614 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | CD8 |
| Chromosome | 2p11.2 (CD8A), 2p11.2 (CD8B) |
| Protein Family | Immunoglobulin superfamily |
| Protein Type | Receptor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | ~25-32 kDa (heterodimer) |
| Pathways | Adaptive Immunity, Amyloid, Apoptosis, Autophagy, Cholesterol |
| UniProt ID | P01732 (CD8A), P10966 (CD8B) |
| GeneCards | CD8 |
| Human Protein Atlas | CD8 |
| Associated Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis, Arthritis |
| Known Drugs/Compounds | dimethyl fumarate |
| Interactions | ACETYL-COA, Actin, AGING, Akt, AKT, ALPHA-SYNUCLEIN |
| KG Connections | 1114 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
CD8(["CD8"])
Cancer["Cancer"]
Tumor["Tumor"]
Als["Als"]
Inflammation["Inflammation"]
GENES(["GENES"])
CANCER(["CANCER"])
INFLAMMATION(["INFLAMMATION"])
Lung_Cancer["Lung Cancer"]
STING(["STING"])
Checkpoint_Inhibitor["Checkpoint Inhibitor"]
Immunotherapy["Immunotherapy"]
CD8 -->|"activates"| Cancer
CD8 -->|"activates"| Tumor
CD8 -->|"therapeutic target"| Cancer
CD8 -->|"activates"| Als
CD8 -.->|"inhibits"| Cancer
CD8 -->|"activates"| Inflammation
GENES -->|"activates"| CD8
CANCER -->|"activates"| CD8
CANCER -->|"therapeutic target"| CD8
INFLAMMATION -->|"activates"| CD8
CD8 -.->|"inhibits"| Tumor
CD8 -->|"activates"| Lung_Cancer
CD8 -->|"activates"| STING
CD8 -->|"activates"| Checkpoint_Inhibitor
CD8 -->|"therapeutic target"| Immunotherapy
style CD8 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Tumor | inhibits | disease | 0.95 |
| T CELLS | interacts_with | cell_type | 0.95 |
| Lung Cancer | activates | disease | 0.95 |
| T cells | associated_with | cell_type | 0.90 |
| Immunotherapy | therapeutic_target | pathway | 0.90 |
| STING | activates | gene | 0.90 |
| Checkpoint Inhibitor | activates | pathway | 0.90 |
| Tumor Microenvironment | activates | pathway | 0.90 |
| Immune Checkpoint | activates | pathway | 0.90 |
| Als | expressed_in | disease | 0.85 |
| Carcinoma | therapeutic_target | disease | 0.85 |
| Cancer | regulates | disease | 0.85 |
| Tumor | regulates | disease | 0.85 |
| Tumor | associated_with | disease | 0.85 |
| Carcinoma | activates | disease | 0.85 |
| Tumor | therapeutic_target | disease | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| Als | inhibits | disease | 0.85 |
| oxidative stress response | participates_in | pathway | 0.80 |
| Glioblastoma | biomarker_for | disease | 0.80 |
| T cells | expressed_in | cell_type | 0.80 |
| T CELLS | activates | cell_type | 0.80 |
| T cells | activates | cell_type | 0.80 |
| MYC | activates | gene | 0.80 |
| Immunotherapy | activates | pathway | 0.80 |
| Immune Response | inhibits | pathway | 0.80 |
| CD4 | associated_with | gene | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Autophagy | activates | pathway | 0.80 |
| Phagocytosis | activates | pathway | 0.80 |
| MICROGLIA | activates | gene | 0.80 |
| IFN | activates | gene | 0.80 |
| Cancer | expressed_in | disease | 0.75 |
| Carcinoma | inhibits | disease | 0.75 |
| Carcinoma | expressed_in | disease | 0.75 |
| Als | causes | disease | 0.75 |
| Als | regulates | disease | 0.75 |
| Aging | inhibits | disease | 0.75 |
| Inflammation | associated_with | disease | 0.75 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.75 |
| Aging | activates | disease | 0.75 |
| Parkinson | expressed_in | disease | 0.75 |
| Inflammation | expressed_in | disease | 0.75 |
| Senescence | inhibits | disease | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| INFLAMMATION | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| APOPTOSIS | activates | gene | 0.90 |
| Maladaptive Microglia Activation | associated_with | process | 0.85 |
| CD19 | associated_with | gene | 0.80 |
| CCL5 | activates | gene | 0.80 |
| STING | activates | gene | 0.80 |
| CANCER | inhibits | gene | 0.80 |
| GENES | associated_with | gene | 0.80 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.70 |
| GSDME | activates | gene | 0.70 |
| TREX1 | activates | gene | 0.70 |
| CD4 | inhibits | gene | 0.70 |
| STAT3 | activates | gene | 0.70 |
| EGFR | activates | gene | 0.70 |
| CANCER | expressed_in | gene | 0.70 |
| AGING | inhibits | gene | 0.70 |
| MHC-I | inhibits | gene | 0.70 |
| CANCER | regulates | gene | 0.70 |
| PHAGOCYTOSIS | activates | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| APOPTOSIS | inhibits | gene | 0.70 |
| cxcl10 | activates | protein | 0.70 |
| INFLAMMATION | expressed_in | gene | 0.70 |
| PARKINSON | expressed_in | gene | 0.70 |
| CXCL10 | activates | gene | 0.70 |
| CD40 | activates | gene | 0.70 |
| CD4 | therapeutic_target | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| glycogen_metabolism | regulates | pathway | 0.64 |
| beta_hydroxybutyrate | regulates | drug | 0.64 |
| CXCR3 | therapeutic_target | gene | 0.60 |
| RIPK3 | activates | gene | 0.60 |
| RIPK1 | activates | gene | 0.60 |
| STAR | expressed_in | gene | 0.60 |
| MELK | activates | gene | 0.60 |
| CIITA | activates | gene | 0.60 |
| MAF | inhibits | gene | 0.60 |
| ANGPT1 | activates | gene | 0.60 |
| IRF1 | activates | gene | 0.60 |
| GFAP | regulates | gene | 0.60 |
| CAMK4 | therapeutic_target | gene | 0.60 |
| RAB7A | regulates | gene | 0.60 |
| TLR7 | interacts_with | gene | 0.60 |
| MTOR | expressed_in | gene | 0.60 |
| OPA1 | associated_with | gene | 0.60 |
| GAIN | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid L | 0.710 | Alzheimer's disease, Parkinson's disease | - |
| Paraneoplastic myelopathies involve CD8+ T cell recognition | 0.450 | neuroinflammation | What are the specific pathophysiological |
Scientific analyses that reference this entity
neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.698
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning CD8 in their description or question text
No additional research found